Author Question: A male patient with hepatitis C will begin triple drug therapy with pegylated interferon alfa 2a ... (Read 91 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
A male patient with hepatitis C will begin triple drug therapy with pegylated interferon alfa 2a (Pegasys), ribavirin (Ribasphere), and boceprevir (Victrelis). The patient tells the nurse that his wife is pregnant. What will the nurse tell him?
 
  a. Boceprevir is contraindicated in males whose partners are pregnant.
  b. He should use a barrier contraceptive when having sex.
  c. He should use dual drug therapy with pegylated interferon alfa and ribavirin only.
  d. This combination drug therapy is safe for him to use.

Question 2

A patient has a positive test for hepatitis C and is admitted to the hospital. The admission laboratory tests reveal a normal ALT, and a liver biopsy is negative for hepatic fibrosis and inflammation. The nurse will prepare this patient for:
 
  a. dual therapy with pegylated interferon alfa and ribavirin.
  b. no medication therapy at this time.
  c. pegylated interferon alfa only until ALT levels are elevated.
  d. triple drug therapy with pegylated interferon alfa, ribavirin, and boceprevir.



Jossy

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

ANS: A
The triple combination is dangerous for pregnant women whose partners are using it, so it is contraindicated for any man whose partner is pregnant. Barrier contraceptives should be used by couples when either partner is taking the triple combination therapy to prevent pregnancy. Ribavirin is teratogenic and is not safe when a partner is pregnant. This combination is not safe for pregnant women whose partners are taking these drugs.

Answer to Question 2

ANS: B
Current recommendations are that treatment is used only for patients with HCV viremia, persistent elevation of ALT, and evidence of hepatic fibrosis and inflammation upon liver biopsy. Dual therapy has been the regimen of choice for patients with the above symptoms, but the addition of a protease inhibitor has been shown to improve outcomes. It is not correct to give pegylated interferon alfa until ALT levels are elevated. Triple drug therapy is used for patients with the above symptoms.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
Both answers were spot on, thank you once again



Jossy

  • Sr. Member
  • ****
  • Posts: 336

 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

Never take aspirin without food because it is likely to irritate your stomach. Never give aspirin to children under age 12. Overdoses of aspirin have the potential to cause deafness.

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

For a complete list of videos, visit our video library